Rolf-Guenther Werner

Title: Rolf-Guenther Werner: Innovator in Recombinant Protein Production

Introduction

Rolf-Guenther Werner is a notable inventor based in Biberach, Germany. He has made significant contributions to the field of biotechnology, particularly in the production of recombinant proteins. With a total of 3 patents to his name, his work has advanced the methods used in thrombolysis and protein production.

Latest Patents

Werner's latest patents include innovative methods for large-scale production of recombinant DNA-derived tissue plasminogen activator (tPA) and K2S molecules. The first patent focuses on the production of tPA or K2S in prokaryotic cells, ensuring that these proteins are secreted extracellularly as active and correctly folded proteins. This method utilizes a vector that contains DNA coding for tPA or K2S, operably linked to the DNA coding for the signal peptide OmpA. The second patent addresses large-scale protein production in prokaryotes, emphasizing the secretion of heterologous proteins in a similar manner.

Career Highlights

Rolf-Guenther Werner is currently employed at Boehringer Ingelheim International GmbH, where he continues to innovate in the field of protein production. His work has been instrumental in developing efficient methods that enhance the production of therapeutic proteins.

Collaborations

Throughout his career, Werner has collaborated with talented individuals such as Jiradej Manosroi and Aranya Manosroi. These collaborations have contributed to the advancement of his research and the successful implementation of his patented methods.

Conclusion

Rolf-Guenther Werner's contributions to biotechnology through his patents and work at Boehringer Ingelheim International GmbH highlight his role as a key innovator in the field of recombinant protein production. His advancements continue to impact the development of therapeutic proteins, showcasing the importance of innovation in biotechnology.